Monday , October 23 2017
Home / KEEP BUT DO NOT DISPLAY / Alerts / Linagliptin, FreeStyle Navigator CGMS System, and EpiPen

Linagliptin, FreeStyle Navigator CGMS System, and EpiPen

Linagliptin has received approval in Europe for the treatment of type 2 diabetes.

Abbott is permanently discontinuing the FreeStyle Navigator CGMS System in the U.S. Supplies will continue to be available until March 2012.

EpiPen and EpiPen Jr single packages have been discontinued and will be supplied in 2-Paks only.